InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
63,083.77
(
-0.19%
)
Post# of 253168
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 260
Posts 18187
Boards Moderated 0
Alias Born 01/19/2006

north40000

Re: DewDiligence post# 209420

Sunday, 02/26/2017 6:05:28 PM

Sunday, February 26, 2017 6:05:28 PM

Post# of 253168
Amarin's Phase 3 Reduce-It study of Vascepa/statin was continued, per 2016 DSMB/IDMC recommendation at planned 1st interim. 2nd interim look planned in 2017, including result data for PI and at least 30 secondary indications. Enrollment > 8000.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up